CIK 0001438533 · Large accelerated filer
Travere Therapeutics, Inc.
Sign in to watch- Ticker
- TVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 262383102
- Phone
- 888-969-7879
- Business address
- 3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Retrophin, Inc., Desert Gateway, Inc.
- 4 Open-market sale SVP, GC & CORPORATE SECRETARY sold 2,062 shares at $8.96 ($18,476)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 7,873 shares at $8.96 ($70,542)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 853 shares at $9.07 ($7,735)
- 4 Open-market sale SENIOR VICE PRESIDENT, R&D sold 2,062 shares at $8.96 ($18,476)
- 4 Open-market sale SVP, CHIEF ACCOUNTING OFFICER sold 910 shares at $9.07 ($8,252)
- 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 1,559 shares at $9.07 ($14,138)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Results of operations
- 4 Open-market sale Chief Medical Officer sold 2,509 shares at an average $9.43 ($23,648)
- 8-K Event Exit or restructuring costs · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale Chief Commercial Officer sold 3,091 shares at $8.25 ($25,504)
- 8-K Event Other events
- 8-K/A Event Exhibits
Page 20 of 65 · 1,286 filings